Balancing Lymphedema Risk
- 1 January 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Exercise and Sport Sciences Reviews
- Vol. 38 (1), 17-24
- https://doi.org/10.1097/jes.0b013e3181c5cd5a
Abstract
Lymphedema, a common and feared negative effect of breast cancer treatment, is generally described by arm swelling and dysfunction. Risk averse clinical recommendations guided survivors to avoid the use of the affected arm. This may lead to deconditioning and, ironically, the very outcome women seek to avoid. Recently published studies run counter to these guidelines.Keywords
This publication has 31 references indexed in Scilit:
- Physical activity and lymphedema (the PAL trial): Assessing the safety of progressive strength training in breast cancer survivorsContemporary Clinical Trials, 2009
- Lymphedema in Breast Cancer Survivors: Incidence, Degree, Time Course, Treatment, and SymptomsJournal of Clinical Oncology, 2009
- Diagnosis and Management of Lymphatic Vascular DiseaseJournal of the American College of Cardiology, 2008
- Is There Enhanced Lymphatic Function in Upper Body Trained Females?Lymphatic Research and Biology, 2008
- Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White womenBreast Cancer Research and Treatment, 2008
- Prognosis of the upper limb following surgery and radiation for breast cancerBreast Cancer Research and Treatment, 2007
- Progressive resistance training in breast cancer: a systematic review of clinical trialsBreast Cancer Research and Treatment, 2007
- Effects of weight training on quality of life in recent breast cancer survivorsCancer, 2006
- Lymphedema managementSeminars in Radiation Oncology, 2003
- The grading of lymphedema in oncology clinical trialsSeminars in Radiation Oncology, 2003